Jeffrey D. Erb, has created a culture of innovation at HealixGlobal — status quo is not in our vocabulary. He constantly encourages his team to look for ways to adjust our thinking and that of our clients to break down barriers and expand the reach of our clients’ brands.
Jeff is changing healthcare media buying with the incorporation of psychological and behavioral data to improve targeting and engagement – something that has been elusive in this highly regulated industry. He is responsible for organizing this move to bring unprecedented levels of qualitative and quantitative analytics to the forefront of the creative planning process through the development of Healix’s proprietary analytics tool, DNA. DNA allows us to layer traditional qualitative marketing data with the psychology of human qualitative engagement and allow us to see not only the what, where, when and how people engage with a communication program, but also the “why” people engage the way they do — all anonymously and within HIPAA guidelines. This gives brands a tool to better understand how their messages are driving openness to recommendations and, ultimately, scripts.
Jeff was honored at the awards reception held October 9 at the 2018 DTC Forum on Social Media & Technology.
For a list of all honorees, click here.
